Agency Information Collection Activities: Proposed Collection; Comments Requested: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms); Order Form Requisition DEA Form 222, 222a, Controlled Substances Order System, 20710 [2011-8748]

Download as PDF 20710 Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices date of this publication comments relating to the Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States of America v. John Williams, Jr., Civil Action No. 11–00689–PHX–MEA (U.S.D.C. D. AZ) (DOJ Ref. No. 90–11– 3–09420). The Consent Decree may be examined at U.S. Environmental Protection Agency, Office of Regional Counsel, EPA IX at 75 Hawthorne Street, San Francisco, California 94105. During the public comment period, the Consent Decree may also be examined on the following Department of Justice Web site, https://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Consent Decree may also be obtained by mail from the Consent Decree Library, U.S. Department of Justice, P.O. Box 7611, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $7.75 (25 cents per page reproduction cost) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. Henry Friedman, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2011–8912 Filed 4–12–11; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0010] mstockstill on DSKH9S0YB1PROD with NOTICES Agency Information Collection Activities: Proposed Collection; Comments Requested: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms); Order Form Requisition DEA Form 222, 222a, Controlled Substances Order System 60-Day Notice of Information Collection Under Review. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for VerDate Mar<15>2010 18:37 Apr 12, 2011 Jkt 223001 review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until June 13, 2011. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Cathy A. Gallagher, Acting Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 307–7297. Written comments concerning this information collection should be sent to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: DOJ Desk Officer. The best way to ensure your comments are received is to e-mail them to oira_submission@omb.eop.gov or fax them to 202–395–7285. All comments should reference the 8 digit OMB number for the collection or the title of the collection. If you have questions concerning the collection, please call Cathy A. Gallagher at 202–307–7297 or the DOJ Desk Officer at 202–395–3176. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of information collection 1117–0010: PO 00000 Frm 00088 Fmt 4703 Sfmt 9990 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: U.S. Official Order Forms for Schedule I and II Controlled Substances (Accountable Forms); Order Form Requisition. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: DEA Forms 222 and 222a. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit; State, local, or tribal government. Abstract: DEA–222 is used to transfer or purchase Schedule I and II controlled substances and data are needed to provide an audit of transfer and purchase. DEA–222a Requisition Form is used to obtain the DEA–222 Order Form. Persons may also digitally sign and transmit orders for controlled substances electronically, using a digital certificate. Orders for Schedule I and II controlled substances are archived and transmitted to DEA. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that 109,632 registrants participate in this information collection, taking an estimated 17.33 hours per registrant annually. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that there are 1,898,970 annual burden hours associated with this collection. If additional information is required contact: Lynn Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, U.S. Department of Justice, Two Constitution Square, 145 N Street, NE., Room 2E– 808, Washington, DC 20530. Dated: April 7, 2011. Lynn Murray, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. 2011–8748 Filed 4–12–11; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\13APN1.SGM 13APN1

Agencies

[Federal Register Volume 76, Number 71 (Wednesday, April 13, 2011)]
[Notices]
[Page 20710]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8748]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0010]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested: U.S. Official Order Forms for Schedule I and II 
Controlled Substances (Accountable Forms); Order Form Requisition DEA 
Form 222, 222a, Controlled Substances Order System

ACTION: 60-Day Notice of Information Collection Under Review.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. Comments are encouraged and will be accepted 
until June 13, 2011. This process is conducted in accordance with 5 CFR 
1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Cathy A. Gallagher, Acting Chief, Liaison 
and Policy Section, Office of Diversion Control, Drug Enforcement 
Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 
307-7297.
    Written comments concerning this information collection should be 
sent to the Office of Information and Regulatory Affairs, Office of 
Management and Budget, Attn: DOJ Desk Officer. The best way to ensure 
your comments are received is to e-mail them to oira_submission@omb.eop.gov or fax them to 202-395-7285. All comments should 
reference the 8 digit OMB number for the collection or the title of the 
collection. If you have questions concerning the collection, please 
call Cathy A. Gallagher at 202-307-7297 or the DOJ Desk Officer at 202-
395-3176.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.
    Overview of information collection 1117-0010:
    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: U.S. Official Order Forms for 
Schedule I and II Controlled Substances (Accountable Forms); Order Form 
Requisition.
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection:
    Form Number: DEA Forms 222 and 222a.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: Not-for-profit; State, local, or tribal government.
    Abstract: DEA-222 is used to transfer or purchase Schedule I and II 
controlled substances and data are needed to provide an audit of 
transfer and purchase. DEA-222a Requisition Form is used to obtain the 
DEA-222 Order Form. Persons may also digitally sign and transmit orders 
for controlled substances electronically, using a digital certificate. 
Orders for Schedule I and II controlled substances are archived and 
transmitted to DEA.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that 109,632 registrants participate in this information collection, 
taking an estimated 17.33 hours per registrant annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: It is estimated that there are 1,898,970 annual 
burden hours associated with this collection.
    If additional information is required contact: Lynn Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, U.S. Department of Justice, Two Constitution 
Square, 145 N Street, NE., Room 2E-808, Washington, DC 20530.

    Dated: April 7, 2011.
Lynn Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2011-8748 Filed 4-12-11; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.